Chinese outlet Interface News interviewed Wafaa El-Sadr, MD, MPH, MPA, ICAP’s global director, for an April 29 article on the U.S. COVID-19 response in the three months since the total number of cases globally passed the one-million mark.
Although there is a point that the antibody test is used to screen immune populations on a large scale, El-Sadr pointed out to Interface News: “It is too early (to judge the role of the antibody test). It is not known what proportion of humans produce antibodies after being infected with the new coronavirus, it is not yet known how long these antibodies will last, and it is not known whether these antibodies provide lasting immunity.”
Read the full article on Sina.com
This article was picked up by aggregator Jiemian.com
Read the latest ICAP updates on COVID-19 here
